糖化白蛋白临床应用的新进展  

Progress in clinical application of glycated albumin

作　　者：张诗田[1] 王雅茹 牛文彦[1] Zhang Shitian;Wang Yaru;Niu Wenyan(Clinical Laboratory,Tianjin Medical University Chu Hsien-I Memorial Hospital,Tianjin Institute of Endocrinology,NHC Key Laboratory of Hormones and Development(Tianjin Medical University),Tianjin Key Laboratory of Metabolic Diseases,Tianjin 300134,China)

机构地区：[1]天津医科大学朱宪彝纪念医院检验科,国家卫生健康委员会激素与发育重点实验室,天津市代谢性疾病重点实验室,天津300134

出　　处：《中华检验医学杂志》2019年第11期909-913,共5页Chinese Journal of Laboratory Medicine

基　　金：国家自然科学基金(81670731,81870547,81170740);天津市科学技术局基金(15JCZDJC35500);天津市卫生健康委员会基金(15KG102)。

摘　　要：及时准确的监测血糖,有效管理血糖水平对治疗糖尿病和预防并发症至关重要。糖化白蛋白是评估血糖波动的重要指标之一,已越来越多地应用于临床。了解糖化白蛋白在血糖评价中的优势和局限性,有助于正确应用此指标评估血糖。Monitoring blood glucose level timely and accurately and management of glucose level is crucial for the treatment of diabetes and the prevention of diabetic complications.Glycated albumin is one of the important biomarker to evaluate the fluctuation of blood glucose level,which has been widely used in clinic.To understand the advantages and limitations of the glycated albumin in monitoring glucose level will contribute to its better application in clinic.

关 键 词：糖化白蛋白 血糖评估 

分 类 号：R58[医药卫生—内分泌]